« Back to Record
Tannock, I. I., Fizazi, K., Ivanov, S., Karlsson, C. T., Fléchon, A., Skoneczna, I., Orlandi, F., Gravis, G., Matveev, V., Bavbek, S., Gil, T., Viana, L., Arén, O., Karyakin, O., Elliott, T., Birtle, A., Magherini, E., Hatteville, L., Petrylak, D., Tombal, B., & Rosenthal, M. (2013). Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): A phase 3, double-blind randomised trial. Lancet oncology, 14(8), 760-768. doi:10.1016/S1470-2045(13)70184-0
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/184098



